Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Lannett Co Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 534,041
  • Shares Outstanding, K 38,010
  • Annual Sales, $ 633,340 K
  • Annual Income, $ -580 K
  • 36-Month Beta 2.51
  • Price/Sales 0.84
  • Price/Cash Flow 3.63
  • Price/Book 0.99

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.70 +2.55%
on 06/22/18
17.15 -18.08%
on 05/30/18
-2.70 (-16.12%)
since 05/22/18
3-Month
13.15 +6.84%
on 05/09/18
17.58 -20.06%
on 04/18/18
-2.45 (-14.85%)
since 03/22/18
52-Week
13.15 +6.84%
on 05/09/18
30.35 -53.71%
on 12/13/17
-5.95 (-29.75%)
since 06/22/17

Most Recent Stories

More News
Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant

Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant

CELG : 78.80 (-0.43%)
LCI : 14.05 (+0.36%)
GILD : 71.07 (-0.63%)
VRX : 24.27 (-1.82%)
BIIB : 296.04 (-0.44%)
Drug Stocks: The Next Hot Industry or Value Traps?

These 5 stocks look dirt cheap but is it too good to be true?

CELG : 78.80 (-0.43%)
LCI : 14.05 (+0.36%)
GILD : 71.07 (-0.63%)
VRX : 24.27 (-1.82%)
BIIB : 296.04 (-0.44%)
Free Stock Performance Review on Mallinckrodt and Three Additional Generic Drugs Stocks

Stock Research Monitor: GALT, KPTI, and LCI

GALT : 7.67 (-0.52%)
LCI : 14.05 (+0.36%)
KPTI : 18.68 (-0.80%)
Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Levofloxacin Oral Solution...

LCI : 14.05 (+0.36%)
Lannett Receives FDA Approval For Dronabinol Capsules

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dronabinol Capsules USP,...

LCI : 14.05 (+0.36%)
ABBV : 93.49 (-2.16%)
Downtrend Call Working As Lannett Co Inc Stock Falls 38.1% (LCI)

SmarTrend identified a Downtrend for Lannett Co Inc (NYSE:LCI) on December 21st, 2017 at $25.38. In approximately 5 months, Lannett Co Inc has returned 38.13% as of today's recent price of $15.70.

LCI : 14.05 (+0.36%)
Lannett Announces Fiscal 2018 Third-Quarter Financial Results

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2018 third quarter ended March 31, 2018.

LCI : 14.05 (+0.36%)
Lannett Company, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2018 / Lannett Company, Inc. (NYSE: ) will be discussing their earnings results in their Q3 Earnings Call to be held on May 7, 2018 at 4:30 PM Eastern Time.

LCI : 14.05 (+0.36%)
Lannett Acquires Portfolio Of Generic Products From Endo International

Lannett Company, Inc. (NYSE: LCI) today announced that it has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International plc for an upfront payment plus future...

LCI : 14.05 (+0.36%)
Lannett To Participate At Two Investor Conferences In May

Lannett Company, Inc. (NYSE: LCI) today announced its participation at two upcoming investor conferences. Schedule below:

LCI : 14.05 (+0.36%)
DB : 11.01 (+1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade LCI with:

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

2nd Resistance Point 14.52
1st Resistance Point 14.28
Last Price 14.05
1st Support Level 13.76
2nd Support Level 13.47

See More

52-Week High 30.35
Fibonacci 61.8% 23.78
Fibonacci 50% 21.75
Fibonacci 38.2% 19.72
Last Price 14.05
52-Week Low 13.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar